The Human Microbiome Project milestone announced
On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
Scientists decoded genome of Chagas disease
On Jun. 5, 2012, an international team of scientists decoded genome of Chagas disease. Previously, scientists had only…
U.S. Dept of HHS Inspector General released report titled “Vaccines for Children Program: Vulnerabilities in Vaccine Management”
On Jun. 5, 2012, the U.S. Department of Health and Human Services (HHS) Office of the Inspector General…
First patent application granted for CRISPR-Cas9 gene editing in all environments
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
AZBio led a cross industry coalition to amend Arizona’s Open Records Law
May 22, 2012, AZBio led a cross industry coalition to amend Arizona’s Open Records Law to make the…
Biotechnology | Disease | FDA | Therapeutics
FDA approved orphan drug Elelyso to treat a form of Gaucher disease
On May 1, 2012, the U.S. Food and Drug Administration (FDA) approved new orphan drug Elelyso to treat…
Hologic acquired Gen-Probe for $37 billion
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
Treatment outcomes in black and white children with cancer was published
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
The USDA confirmed detection of Bovine Spongiform Encephalopathy (BSE) in California
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
Washington State Secretary of Health declared a pertussis epidemic
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. By June 16, the…
Biotechnology | CDC | Oncology | Therapeutics
Report to the nation finds continuing declines in cancer death rates since the early 1990s
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
OHSU’s Oregon National Primate Research Center opened dedicated lab space
On Mar. 27, 2012, the Oregon National Primate Research Center at OHSU dedicated a new home for its…
The Priestley Medal was awarded to Robert S. Langer
On Mar. 27, 2012, the American Chemical Society awarded the Priestley Medal to Robert S. Langer “to recognize…
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
Draft sequence of the gorilla genome was published
On Mar. 8, 2012, an international team led by researchers at the Wellcome Trust Sanger Institute announced they…
OHSU-led consortium awarded $21 million grant to study alcoholism, stress
On Mar. 8, 2012, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a five-year, $21 million…
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
Biotechnology | Disease | FDA | Therapeutics
The FDA approved Korlym for patients with endogenous Cushing’s syndrome
On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…
Entire genome of extinct Denisovan human decoded from fossil
On Feb. 7, 2012, The Max Planck Institute for Evolutionary Anthropology, in Leipzig, Germany, completed the genome sequence…
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Jan. 31, 2012, the U.S. Food and Drug Administration (FDA) granted Gleevec (imatinib) regular approval for use…
The FDA approved KALYDECO (ivacaftor) a University of Washington-tested drug to treat the genetic mechanism of cystic fibrosis
On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…
Biotechnology | FDA | Oncology | Therapeutics
The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
The UC San Diego Health System acquired the Nevada Cancer Institute
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
Revive & Restore was founded
In 2012, Ryan Phelan and Stewart Brand founded the Revive & Restore project within The Long Now Foundation,…
Renowned biochemist Michael A Marletta became president and CEO of The Scripps Research Institute
On Jan 1, 2012, renowned biochemist Michael A. Marletta became president and CEO of The Scripps Research Institute…
Alan Aderem, PhD, became president of Seattle BioMed – only the second in its more than 35-year history
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
Vaccines containing cell-cultured virus became available
In 2012, vaccines containing cell-cultured virus became available. Even though eggs continued to be the primary means of…
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Comprehensive Cancer Center received NCI designation
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…